Scholarlink

Background <p>The present work aims to develop and validate an LC–MS/MS method for the bioanalysis of a fixed-dose combination containing 325&#xa0;mg of paracetamol and 50&#xa0;mg of camylofin in human serum.</p> Results <p>A selective, sensitive and fast LC–MS/MS method was developed and validated for quantitative bioanalysis of the analytes from human serum, using protein precipitation technique and diphenylamine as an internal standard (IS). Chromatographic separation was performed on Agilent Zorbax SB C18 column (50&#xa0;mm × 2.1&#xa0;mm, 5&#xa0;μm), using a mixture of 0.1% formic acid and methanol (50: 50 v/v) as mobile phase at a flow rate of 0.5&#xa0;mL/min, with a run time of 6&#xa0;min. Tandem mass spectrometry (MS/MS) was employed for the analysis, utilising positive ionisation mode and a multiple reaction monitoring (MRM) scan type. The method was established with a linear range of 100–20,000&#xa0;ng/mL for paracetamol and 0.25–200&#xa0;ng/mL for camylofin using 200&#xa0;μL of human serum.</p> Conclusion <p>The developed bioanalytical method was validated as per the Bioanalytical Method Validation Guidance for Industry of the United States Food and Drug Administration (US-FDA)-CDER. The developed method is reliable and easy to use and was applied successfully to a clinical pharmacokinetic study involving twelve healthy Indian subjects under fasting and fed conditions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Development and validation of an LC–MS/MS method for quantification of paracetamol and camylofin in human serum

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年9月30日

查看全文
  • Aditya Anil Kulkarni,
  • Krishnapriya Mohanraj

摘要

Background

The present work aims to develop and validate an LC–MS/MS method for the bioanalysis of a fixed-dose combination containing 325 mg of paracetamol and 50 mg of camylofin in human serum.

Results

A selective, sensitive and fast LC–MS/MS method was developed and validated for quantitative bioanalysis of the analytes from human serum, using protein precipitation technique and diphenylamine as an internal standard (IS). Chromatographic separation was performed on Agilent Zorbax SB C18 column (50 mm × 2.1 mm, 5 μm), using a mixture of 0.1% formic acid and methanol (50: 50 v/v) as mobile phase at a flow rate of 0.5 mL/min, with a run time of 6 min. Tandem mass spectrometry (MS/MS) was employed for the analysis, utilising positive ionisation mode and a multiple reaction monitoring (MRM) scan type. The method was established with a linear range of 100–20,000 ng/mL for paracetamol and 0.25–200 ng/mL for camylofin using 200 μL of human serum.

Conclusion

The developed bioanalytical method was validated as per the Bioanalytical Method Validation Guidance for Industry of the United States Food and Drug Administration (US-FDA)-CDER. The developed method is reliable and easy to use and was applied successfully to a clinical pharmacokinetic study involving twelve healthy Indian subjects under fasting and fed conditions.